Detalhe da pesquisa
1.
Regression calibration of self-reported mobile phone use to optimize quantitative risk estimation in the COSMOS study.
Am J Epidemiol
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751312
2.
Tumour-educated platelets for breast cancer detection: biological and technical insights.
Br J Cancer
; 128(8): 1572-1581, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765174
3.
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence.
J Med Genet
; 59(12): 1206-1218, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162851
4.
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.
Breast Cancer Res Treat
; 194(1): 159-170, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507134
5.
A Multipollutant Approach to Estimating Causal Effects of Air Pollution Mixtures on Overall Mortality in a Large, Prospective Cohort.
Epidemiology
; 33(4): 514-522, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384897
6.
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Genet Med
; 22(10): 1653-1666, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665703
7.
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
Br J Cancer
; 121(2): 180-192, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31213659
8.
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 177(3): 723-733, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31302855
9.
Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insights.
Br J Cancer
; 129(4): 734, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488450
10.
Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers.
Br J Cancer
; 119: 357-363, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29937543
11.
The Authors Respond.
Epidemiology
; 33(6): e21-e22, 2022 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220584
12.
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
JAMA
; 317(23): 2402-2416, 2017 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632866
13.
Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.
JAMA
; 316(3): 300-12, 2016 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27434442
14.
Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Int J Cancer
; 136(3): 668-77, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24947112
15.
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations.
J Med Genet
; 51(2): 98-107, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24285858
16.
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.
Int J Cancer
; 135(12): 2940-9, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24789418
17.
The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses.
BMC Cancer
; 14: 47, 2014 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24475944
18.
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
PLoS Biol
; 9(11): e1001199, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22110403
19.
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
Hum Mol Genet
; 20(23): 4732-47, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21890493
20.
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
PLoS Genet
; 6(10): e1001183, 2010 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21060860